Bond Screener
Charles River Laboratories International
LEI 549300BSQ0R4UZ5KX287
Organization name
Charles River Laboratories International, Inc.
Country name
USA
Country of registration
USA
Industry
Professional Services
Credit Ratings
in foreign currency
Public debt
1,500 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
|
General information
-
Organization nameCharles River Laboratories International, Inc.
-
Organization statusOperating organization
-
Address251 Ballardvale Street Wilmington, USA, 01887
-
Site
-
IR Site
News
-
Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call15/07/2026
-
Charles River Laboratories International: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits05/05/2026
-
Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call16/04/2026
-
Charles River Laboratories International, Inc. (NYSE:CRL) Sees Varied Analyst Ratings Amidst Institutional Activity14/04/2026
-
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance18/02/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameCharles River Laboratories International, Inc.
-
Organization statusOperating organization
-
Address251 Ballardvale Street Wilmington, USA, 01887
-
Site
-
IR Site
Codes
-
LEI549300BSQ0R4UZ5KX287
-
SIC8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0001100682
-
EIN06-1397316
